Skip to main content

Table 5 Age-specific comparison of standard gamble utility scores converted using the ‘lifetime duration-early stage cervical cancer’ score

From: A survey of population-based utility scores for cervical cancer prevention

Health state Age groups Wilcoxan rank sum test P value
20-49 years 50-69 years
Mean utility score Median utility score Mean utility score Median utility score
(SE) (IQR) (SE) (IQR)
Cyto normal 0.9996 1.0 0.9994 0.9999 0.9255
(0.0002) (0.9997 -1.0) (0.0003) (0.9998 -1.0)
HPV vaccination 0.9998 1.0 0.9960 1.0 0.8408
(<0.0000) (0.9998 - 1.0) (0.0034) (0.9998 - 1.0)
LG cyto 0.9996 1.0 0.9965 1.0 0.8174
(0.0002) (0.9997 -1.0) (0.0032) (1.0 -1.0)
LG cyto with colp normal 0.9985 0.9999 0.9956 0.9999 0.8933
(0.0086) (0.9996 - 1.0) (0.0032) (0.9997 - 1.0)
HPV positive with cyto normal 0.9986 0.9999 0.9956 0.9999 0.786
(0.0009) (0.9997 - 1.0) (0.0032) (0.9997 - 1.0)
HPV positive with colp normal 0.9987 0.9999 0.9994 1.0 0.2892
(0.0009) (0.9997 - 1.0) (0.0003) (0.9998 - 1.0)
Treated genital warts 0.9983 0.9998 0.9957 0.9999 0.8211
(0.0010) (0.9994 - 1.0) ( 0.0034) (0.9997 - 1.0)
HG cyto with CIN 1 0.9989 0.9999 0.9922 0.9998 0.8517
(0.0007) (0.9996 - 0.9999) (0.0045) ( 0.9997 - 1.0)
HG cyt with CIN 2 or 3 0.9983 0.9997 0.9954 0.9999 0.8733
(0.0010) (0.9994 - 0.9998) (0.0033) (0.9992 - 1.0)
Early stage cervical cancer 0.9732 0.9950 0.9697 0.9850 0.4817
(0.0085) (0.9550 - 0.9950) (0.0066) (0.9450 - 0.9950)
  1. HSPS health state preference score; Cyto cytology; HPV human papillomavirus; LG low grade disease; HG high grade disease; Colp colposcopy; CIN cervical intraepithelial neoplasia; FIGO Fédération Internationale de Gynécologie Obstétrique (International Federation of Gynecology and Obstetrics).